Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

FirstWord Pharma
firstwordpharma.com > story > 7966036

Kura spins out Caspian to take menin inhibitor into diabetes

4+ day, 21+ hour ago   (12+ words) FirstWord Pharma...

firstwordpharma.com
firstwordpharma.com > story > 7964686

Physician Views Results: Eli Lilly's cardiovascular nod for Mounjaro punches above its weight

5+ day, 5+ hour ago   (14+ words) firstwordpharma.com...

firstwordpharma.com
firstwordpharma.com > story > 7942241

Physician Views Preview: Mounjaro closes CV gap, but is it enough to shift prescribing?

1+ week, 4+ day ago   (15+ words) firstwordpharma.com...

FirstWord Pharma
firstwordpharma.com > story > 7898552

Lilly links up with one of its Gateway Labs companies for vaccine collab

3+ week, 3+ day ago   (15+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7897151

Amylyx preps for GLP-1 receptor antagonist launch with $500M share sale

3+ week, 3+ day ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7897250

UK cost-effectiveness body backs Lilly's once-weekly insulin ahead of approval

3+ week, 3+ day ago   (12+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7858690

Enveda to move AI-discovered drug into mid-stage study for weight-loss maintenance

3+ week, 5+ day ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7857423

Amylyx plans FDA filing for avexitide after positive study results in post-bariatric hypoglycaemia

3+ week, 5+ day ago   (15+ words) FirstWord Pharma...